隨著超高齡社會的來臨，高齡長者行動不便以及長期臥病在床等問題，已經造成醫療資源與健保費用的龐大支出，為緩解長者骨質疏鬆症和退化性關節炎，民間常以龜鹿二仙膠補強筋骨。本論文主要研究龜鹿二仙膠對於緩解關節與骨骼退化的替代醫療效果，本研究選用與順天堂科學中藥廠提供的龜鹿二仙膠，龜鹿二仙膠主要藥材包括枸杞、龜板、人參和鹿角。本研究首先利用1,1-二苯基-2-吡啶並肼基（1,1-diphenyl-2-picrylhydrazyl；DPPH）自由基清除能力測試檢視龜鹿二仙膠的抗氧化力；再利用脂多醣（lipopolysaccharide，LPS）處理關節滑膜細胞（HIG-82），藉此誘發關節滑膜細胞（synoviocyte，HIG-82）的發炎現象，透過細胞存活率分析法（3-（4,5-Dimethylthiazol-2-yl）-2,5- diphenyltetrazolium bromide；MTT assay）以及酵素結合免疫吸附分析法（Enzyme-linked immunosorbent；ELISA assay），檢視龜鹿二仙膠是否可以緩解脂多醣（LPS）誘發關節滑膜細胞（HIG-82）的發炎；此外，本研究利用化療藥物阿黴素預先處理，藉此誘發老化小鼠的骨骼疏鬆，然後使用骨骼電腦斷層掃描技術檢視脛骨的骨小樑與骨密度，藉此評估龜鹿二仙膠是否可以緩解化療藥物阿黴素所誘發小鼠的骨質疏鬆。本論文結果顯示龜鹿二仙膠不但可以顯著增強DPPH自由基清除能力，對於脂多醣（LPS）誘發關節滑膜細胞（HIG-82）的發炎，也有顯著的緩解效果；此外，對於化療藥物阿黴素（doxorubicin，DOX）所誘發小鼠的骨質疏鬆，連續餵食龜鹿二仙膠四週後，也有顯著的緩解效果。歸納本研究結果，可以說明龜鹿二仙膠對於緩解關節與骨骼退化確實具有替代醫療效果。研究者認為適時給予中、高齡長者補充龜鹿二仙膠，將有助於緩解高齡長者行動不便以及長期臥病在床等問題，大大降低醫療資源與健保經費的龐大支出。

With the advent of the super-aged society, elders' problems such as mobility problems and long-term bedridden cause huge expenditures on medical resources and health insurance costs. In order to alleviate the osteoporosis and degenerative arthritis of the elders, the people often use the Guilu Erxian Glue （GEG） to relieve the osteoporosis and degenerative arthritis. This thesis mainly studied alternative medical potential of the GEG in relieving joint and bone degeneration. The GEG, provided by Sun Ten Pharmaceutical Co., Ltd., with four main ingredients of ginseng, wolfberry, tortoise plastron and antler from a famous Chinese prescription. In this study. （we used 1,1-diphenyl-2-picrylhydrazyl （DPPH） free radical scavenging assay to examine the antioxidant capacity of the GEG; then we used lipopolysaccharide (LPS） to treats HIG-82 joint synovial cells, thereby inducing the inflammation in HIG-82 cells, through the 3-（4,5-Dimethylthiazol- 2-yl ）-2,5-diphenyltetrazolium bromide （MTT） and enzyme-linked immunosorbent assay （ELISA） to examine whether the GEG can alleviate chemotherapy-induced HIG-82 joint synovial cell toxicity and Inflammation. In addition, we used the doxorubicin （DOX） to induce bone loss in aging mice, and then used bone computer tomography to examine the trabecular density of the tibia, thereby assessing whether the GEG can alleviate the osteoporosis in chemotherapy mice. Our results of this thesis showed that GEG could not only significantly enhance the DPPH free radical scavenging ability, but also had a significant alleviating effect on the toxicity and inflammation of chemotherapy HIG-82 cells. In addition, After feeding GEG for four consecutive weeks, those chemotherapy mice had a significant relief effect in osteoporosis. To summarize our results, the GEG indeed have an alternative medical effect on alleviating joint and bone degeneration. We believe that timely supplementation of GEG to the middle-aged people that should help to alleviate the mobility problems and long-term bedridden problems for elders, and greatly reduce the huge expenditures on medical resources and health insurance costs.

中文參考文獻
尹玉彪（2011）龜鹿二仙膠及其拆方對大鼠軟骨細胞增殖與基質合成的影響。福建中醫藥大學碩士論文。
王香蘋（2004） 1999年台灣地區中老年人健康狀況的探討。弘光學報，43期，95-109頁。
台灣必安研究所（2015）龜鹿二仙膠改善骨質疏鬆症之研究。新醫藥週刊第2564期。
池秀華、蔡敏鈴（2016）龜鹿二仙膠之簡介與臨床應用。藥學雜誌126（32） :54-58。
李文順、李楠、余丹丹（2005）龜鹿二仙膠湯治療膝骨性關節炎的臨床研究。福建中醫學院學報15（6）。
李雅文（2017）龜鹿二仙膠於足球運動員膝關節炎之影響。義守大學化學工程學系暨生物技術與化學工程研究所學位論文。
李楠、杜江、黄遠鹏（2013）龜鹿二仙膠及其拆方對SD大鼠膝關節炎的影響。中華中醫學雜誌28（6）:1677-1680。
周彥瑢（2019）高效能超音波萃取龜鹿二仙膠於骨關節炎的療效研究。輔仁大學應用科學與工程研究所博士論文。
林嘉輝、陳炳藝、李楠（2017）龜鹿二仙膠治療骨關節炎的研究概況。中華中醫藥雜誌2017（12）。
洪宋貞、林毅、司徒紅林（2005）龜鹿二仙丹加味治療乳腺癌化療後骨髓抑制的臨床研究。新中醫37（1）。
國家發展委員會（2020）中華民國2020 至2070 年人口推估報告。
楊丁友、段學忠（2000）龜鹿二仙膠加味治療絕經後婦女不穩定型心絞痛的臨床究。安徽中醫學院學報19（4）。
黎榮興（2006）中藥龜鹿二仙膠對停經後婦女骨質密度的影響。中原大學醫學工程研究所碩士論文。
黎榮興、許忠源、孫盛義（2007）評估雙能量X光骨質密度儀及定量超音波骨質密度儀對服用龜鹿二仙膠後停經婦女骨質密度的影響。中華放射線技術學雜誌31（2） 147-153。
盧訓叢（1999）龜鹿二仙膠方義與應用述要。湖北中醫學院學報1（4）。

英文參考文獻
Angsutararux P, Luanpitpong S, Issaragrisil S. Chemotherapy-Induced Cardiotoxicity: Overview of the Roles of Oxidative Stress. Oxid Med Cell Longev. 2015;2015:795602. doi: 10.1155/2015/795602. Epub 2015 Sep 29. PMID: 26491536; PMCID: PMC4602327.
Ansari L, Shiehzadeh F, Taherzadeh Z, Nikoofal-Sahlabadi S, Momtazi-Borojeni AA, Sahebkar A, Eslami S. The most prevalent side effects of pegylated liposomal doxorubicin monotherapy in women with metastatic breast cancer: a systematic review of clinical trials. Cancer Gene Ther. 2017 May;24（5）:189-193. doi: 10.1038/cgt.2017.9. Epub 2017 Apr 14. PMID: 28409561.
Bagnall-Moreau C, Chaudhry S, Salas-Ramirez K, Ahles T, Hubbard K. Chemotherapy-Induced Cognitive Impairment Is Associated with Increased Inflammation and Oxidative Damage in the Hippocampus. Mol Neurobiol. 2019 Oct;56（10）:7159-7172. doi: 10.1007/s12035-019-1589-z. Epub 2019 Apr 15. PMID: 30989632; PMCID: PMC6728167.
Baird CL et al. （2003） Self-care women with osteoarthritis living at different levels of independence. Health Care for Woman International 24: 617-634.
Barry E, Alvarez JA, Scully RE, Miller TL, Lipshultz SE. Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management. Expert Opin Pharmacother. 2007 Jun;8（8）:1039-58. doi: 10.1517/14656566.8.8.1039. PMID: 17516870.
Brown JC, Huedo-Medina TB, Pescatello LS, Pescatello SM, Ferrer RA, Johnson BT. Efficacy of exercise interventions in modulating cancer-related fatigue among adult cancer survivors: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2011 Jan;20（1）:123-33. doi: 10.1158/1055-9965.EPI-10-0988. Epub 2010 Nov 4. PMID: 21051654.
Cao B, Li M, Zha W, Zhao Q, Gu R, Liu L, Shi J, Zhou J, Zhou F, Wu X, Wu Z, Wang G, Aa J. Metabolomic approach to evaluating adriamycin pharmacodynamics and resistance in breast cancer cells. Metabolomics. 2013;9（5）:960-973. doi: 10.1007/s11306-013-0517-x. Epub 2013 Mar 20. PMID: 24039617; PMCID: PMC3769585.
Chen Y et al. （2020） Chinese herbal medicine Guilu erxian jiao attenuates bone marrow suppression following chemotherapy in patients with advanced lung cancer. Translational Metabolic Syndrome Research 3: 25-28.
Chen Y, Jungsuwadee P, Vore M, Butterfield DA, St Clair DK. Collateral damage in cancer chemotherapy: oxidative stress in nontargeted tissues. Mol Interv. 2007 Jun;7（3）:147-56. doi: 10.1124/mi.7.3.6. PMID: 17609521.
Chou YJ et al. （2018） The potent anti-inflammatory effect of Guilu Erxian Glue extracts remedy joint pain and ameliorate the progression of osteoarthritis in mice. J Orthop Surg Res. 13: 259.
Chou YJ, Chuu JJ, Peng YJ, Cheng YH, Chang CH, Chang CM, Liu HW. The potent anti-inflammatory effect of Guilu Erxian Glue extracts remedy joint pain and ameliorate the progression of osteoarthritis in mice. J Orthop Surg Res. 2018 Oct 19;13（1）:259. doi: 10.1186/s13018-018-0967-y. PMID: 30340603; PMCID: PMC6194592.
Chuang TY, Lien CY, Tsai YC, Lin KF, Hsu CH, Wu WJ, Su LY, Lu CW, Wu CH. Oral treatment with the Chinese herbal supplements B307 enhances muscle endurance of ICR mice after exhaustive swimming via suppressing fatigue, oxidative stress, and inflammation. Food Sci Nutr. 2020 May 19;8（7）:3682-3691. doi: 10.1002/fsn3.1652. PMID: 32724631; PMCID: PMC7382157.
Davis S, Martyn-St James M, Sanderson J, Stevens J, Goka E, Rawdin A, Sadler S, Wong R, Campbell F, Stevenson M, Strong M, Selby P, Gittoes N. A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fractures. Health Technol Assess. 2016 Oct;20（78）:1-406. doi: 10.3310/hta20780. Erratum in: Health Technol Assess. 2018 Mar;20（78）:407-424. PMID: 27801641; PMCID: PMC5107884.
Deeks ED. Denosumab: A Review in Postmenopausal Osteoporosis. Drugs Aging. 2018 Feb;35（2）:163-173. doi: 10.1007/s40266-018-0525-7. Erratum in: Drugs Aging. 2018 Mar 9;: PMID: 29435849.
Dogantekin A, Gurel A, Ustundag B, Ilhan S, Elkiran ET. Oxidative stress and antioxidant parameters in neutropenic patients secondary to chemotherapy. Pak J Med Sci. 2016 Mar-Apr;32（2）:309-13. doi: 10.12669/pjms.322.9200. PMID: 27182229; PMCID: PMC4859012.
E. R. Hayek, E. Speakman, and E. Rehmus, “Acute doxorubicin cardiotoxicity,” New England Journal of Medicine, vol. 352, no. 23, pp. 2456-2457, 2005.View at: Publisher Site | Google Scholar
Ewer MS, Ewer SM. Cardiotoxicity of anticancer treatments: what the cardiologist needs to know. Nat Rev Cardiol. 2010 Oct;7（10）:564-75. doi: 10.1038/nrcardio.2010.121. PMID: 20842180.
Fan C, Georgiou KR, Morris HA, McKinnon RA, Keefe DMK, Howe PR, Xian CJ. Combination breast cancer chemotherapy with doxorubicin and cyclophosphamide damages bone and bone marrow in a female rat model. Breast Cancer Res Treat. 2017 Aug;165（1）:41-51. doi: 10.1007/s10549-017-4308-3. Epub 2017 May 26. PMID: 28550626.
Felson DT. Epidemiology of hip and knee osteoarthritis. Epidemiol Rev. 1988;10:1-28. doi: 10.1093/oxfordjournals.epirev.a036019. PMID: 3066625.
Feng L, Huang Q, Huang Z, Li H, Qi X, Wang Y, Liu Z, Liu X, Lu L. Optimized Animal Model of Cyclophosphamide-induced Bone Marrow Suppression. Basic Clin Pharmacol Toxicol. 2016 Nov;119（5）:428-435. doi: 10.1111/bcpt.12600. Epub 2016 May 27. PMID: 27061017.
Fonseca H, Carvalho A, Esteves J, Esteves VI, Moreira-Gonçalves D, Duarte JA. Effects of doxorubicin administration on bone strength and quality in sedentary and physically active Wistar rats. Osteoporos Int. 2016 Dec;27（12）:3465-3475. doi: 10.1007/s00198-016-3672-x. Epub 2016 Jun 18. PMID: 27318466.
Galantino ML, Desai K, Greene L, Demichele A, Stricker CT, Mao JJ. Impact of yoga on functional outcomes in breast cancer survivors with aromatase inhibitor-associated arthralgias. Integr Cancer Ther. 2012 Dec;11（4）:313-20. doi: 10.1177/1534735411413270. Epub 2011 Jul 6. PMID: 21733988.
Georgescu HI, Mendelow D, Evans CH. HIG-82: an established cell line from rabbit periarticular soft tissue, which retains the "activatable" phenotype. In Vitro Cell Dev Biol. 1988 Oct;24（10）:1015-22. doi: 10.1007/BF02620875. PMID: 2846503. 
Hasinoff BB, Schnabl KL, Marusak RA, Patel D, Huebner E. Dexrazoxane （ICRF-187） protects cardiac myocytes against doxorubicin by preventing damage to mitochondria. Cardiovasc Toxicol. 2003;3（2）:89-99. doi: 10.1385/ct:3:2:89. PMID: 14501028.
Hsu CH, Lin CL, Wang SE, Sheu SJ, Chien CT, Wu CH. Oral treatment with herbal formula B401 alleviates penile toxicity in aging mice with manganism. Clin Interv Aging. 2015 May 28;10:907-18. doi: 10.2147/CIA.S82026. PMID: 26064043; PMCID: PMC4455845.
Hsu CH, Wang SE, Lin CL, Hsiao CJ, Sheu SJ, Wu CH. Neuroprotective Effects of the Herbal Formula B401 in Both Cell and Mouse Models of Alzheimer's Disease. Evid Based Complement Alternat Med. 2016;2016:1939052. doi: 10.1155/2016/1939052. Epub 2016 Sep 28. PMID: 27761145; PMCID: PMC5059538.
Kahwati LC, Weber RP, Pan H, Gourlay M, LeBlanc E, Coker-Schwimmer M, Viswanathan M. Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2018 Apr 17;319（15）:1600-1612. doi: 10.1001/jama.2017.21640. PMID: 29677308.
Kanis JA, Cooper C, Rizzoli R, Reginster JY; Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis （ESCEO） and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation （IOF）. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2019 Jan;30（1）:3-44. doi: 10.1007/s00198-018-4704-5. Epub 2018 Oct 15. Erratum in: Osteoporos Int. 2020 Jan;31（1）:209. Erratum in: Osteoporos Int. 2020 Apr;31（4）:801. PMID: 30324412; PMCID: PMC7026233.
Kilgour RD, Vigano A, Trutschnigg B, Hornby L, Lucar E, Bacon SL, Morais JA. Cancer-related fatigue: the impact of skeletal muscle mass and strength in patients with advanced cancer. J Cachexia Sarcopenia Muscle. 2010 Dec;1（2）:177-185. doi: 10.1007/s13539-010-0016-0. Epub 2010 Dec 17. PMID: 21475694; PMCID: PMC3060645.
Kotian P, Boloor A, Sreenivasan S. Study of Adverse Effect Profile of Parenteral Zoledronic Acid in Female Patients with Osteoporosis. J Clin Diagn Res. 2016 Jan;10（1）:OC04-6. doi: 10.7860/JCDR/2016/17061.7021. Epub 2016 Jan 1. PMID: 26894105; PMCID: PMC4740633.
Lebrecht D, Geist A, Ketelsen UP, Haberstroh J, Setzer B, Walker UA. Dexrazoxane prevents doxorubicin-induced long-term cardiotoxicity and protects myocardial mitochondria from genetic and functional lesions in rats. Br J Pharmacol. 2007 Jul;151（6）:771-8. doi: 10.1038/sj.bjp.0707294. Epub 2007 May 21. PMID: 17519947; PMCID: PMC2014121.
Lewalle A, Land S, Merken JJ, Raafs A, Sepúlveda P, Heymans S, Kleinjans J, Niederer SA. Balance of Active, Passive, and Anatomical Cardiac Properties in Doxorubicin-Induced Heart Failure. Biophys J. 2019 Dec 17;117（12）:2337-2348. doi: 10.1016/j.bpj.2019.07.033. Epub 2019 Jul 29. PMID: 31447110; PMCID: PMC6990149.
Lien CY, Chuang TY, Hsu CH, Lin CL, Wang SE, Sheu SJ, Chien CT, Wu CH. Oral treatment with the herbal formula B307 alleviates cardiac toxicity in doxorubicin-treated mice via suppressing oxidative stress, inflammation, and apoptosis. Onco Targets Ther. 2015 May 26;8:1193-210. doi: 10.2147/OTT.S82936. PMID: 26060405; PMCID: PMC4454207.
Lien CY, Lu CW, Hsu CH, Chuang TY, Su LY, Wu WJ, Jheng YS, Lee MC, Wu CH. Chinese Veterinary Medicine B307 Promotes Cardiac Performance and Skeletal Muscle Contraction via Enhancing Intracellular Calcium Levels and Neural Electrical Activity in Animal and Cell Models. Evid Based Complement Alternat Med. 2020 Oct 28;2020:9064824. doi: 10.1155/2020/9064824. PMID: 33178329; PMCID: PMC7644306.
Long L, Soeken K, Ernst E. Herbal medicines for the treatment of osteoarthritis: a systematic review. Rheumatology （Oxford）. 2001 Jul;40（7）:779-93. doi: 10.1093/rheumatology/40.7.779. PMID: 11477283.
Marques VA, Ferreira-Junior JB, Lemos TV, Moraes RF, Junior JRS, Alves RR, Silva MS, Freitas-Junior R, Vieira CA. Effects of Chemotherapy Treatment on Muscle Strength, Quality of Life, Fatigue, and Anxiety in Women with Breast Cancer. Int J Environ Res Public Health. 2020 Oct 6;17（19）:7289. doi: 10.3390/ijerph17197289. PMID: 33036182; PMCID: PMC7579368.
McCrary JM, Goldstein D, Wyld D, Henderson R, Lewis CR, Park SB. Mobility in survivors with chemotherapy-induced peripheral neuropathy and utility of the 6-min walk test. J Cancer Surviv. 2019 Aug;13（4）:495-502. doi: 10.1007/s11764-019-00769-7. Epub 2019 Jun 6. PMID: 31172429.
Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev. 2004 Jun;56（2）:185-229. doi: 10.1124/pr.56.2.6. PMID: 15169927.
Pisoschi AM, Pop A, Cimpeanu C, Predoi G. Antioxidant Capacity Determination in Plants and Plant-Derived Products: A Review. Oxid Med Cell Longev. 2016;2016:9130976. doi: 10.1155/2016/9130976. Epub 2016 Dec 4. PMID: 28044094; PMCID: PMC5164913.
Rossi LMM, Copes RM, Dal Osto LC, Flores C, Comim FV, Premaor MO. Factors related with osteoporosis treatment in postmenopausal women. Medicine （Baltimore）. 2018 Jul;97（28）:e11524. doi: 10.1097/MD.0000000000011524. PMID: 29995822; PMCID: PMC6076108.
Rubenstein LZ. Falls in older people: epidemiology, risk factors and strategies for prevention. Age Ageing. 2006 Sep;35 Suppl 2:ii37-ii41. doi: 10.1093/ageing/afl084. PMID: 16926202.
Ruiz JR, Sui X, Lobelo F, Morrow JR Jr, Jackson AW, Sjöström M, Blair SN. Association between muscular strength and mortality in men: prospective cohort study. BMJ. 2008 Jul 1;337（7661）:a439. doi: 10.1136/bmj.a439. PMID: 18595904; PMCID: PMC2453303.
Sawyer DB. Is there more for us to learn from oncology?: Examining the implications of anthracycline effects on the young heart. Circulation. 2010 Feb 9;121（5）:623-5. doi: 10.1161/CIR.0b013e3181d2c996. Epub 2010 Jan 25. PMID: 20100976.
Schmidt ME, Wiskemann J, Krakowski-Roosen H, Knicker AJ, Habermann N, Schneeweiss A, Ulrich CM, Steindorf K. Progressive resistance versus relaxation training for breast cancer patients during adjuvant chemotherapy: design and rationale of a randomized controlled trial （BEATE study）. Contemp Clin Trials. 2013 Jan;34（1）:117-25. doi: 10.1016/j.cct.2012.10.006. Epub 2012 Oct 25. PMID: 23103936.
Si Y, Yao Y, Ma Y, Guo Y, Yin H. Effectiveness and safety of Guilu Erxian Glue （a traditional Chinese medicinal product） for the treatment of postmenopausal osteoporosis: A protocol for systematic review and meta-analysis. Medicine （Baltimore）. 2020 Jul 17;99（29）:e20773. doi: 10.1097/MD.0000000000020773. PMID: 32702821; PMCID: PMC7373594.
Tian H et al. （2015） Effects of traditional Chinese medicine on chemotherapy-induced myelosuppression and febrile neutropenia in breast cancer patients. Evid Based Compl Alter Med, 2015: ID 736197.
Tian H, Qin W, Wu W, Guo P, Lu Y, Liu P, Liu Q, Su F. Effects of Traditional Chinese Medicine on Chemotherapy-Induced Myelosuppression and Febrile Neutropenia in Breast Cancer Patients. Evid Based Complement Alternat Med. 2015;2015:736197. doi: 10.1155/2015/736197. Epub 2015 Aug 12. PMID: 26347793; PMCID: PMC4549530.
Tsai CC et al. （2014） Effect of the Herbal Drug Guilu Erxian Jiao on Muscle Strength, Articular Pain, and Disability in Elderly Men with Knee Osteoarthritis. Evidence-Based Complementary and Alternative Medicine Volume 2014, Article ID 297458.
Tsai CC, Chou YY, Chen YM, Tang YJ, Ho HC, Chen DY. Effect of the herbal drug guilu erxian jiao on muscle strength, articular pain, and disability in elderly men with knee osteoarthritis. Evid Based Complement Alternat Med. 2014;2014:297458. doi: 10.1155/2014/297458. Epub 2014 Sep 16. PMID: 25309612; PMCID: PMC4182023.
Vyas D, Laput G, Vyas AK. Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis. Onco Targets Ther. 2014 Jun 12;7:1015-23. doi: 10.2147/OTT.S60114. PMID: 24959088; PMCID: PMC4061164.
Wang PH et al. （2012） Clinical Evaluation of Guilu Erxian Jiao in Treating Perimenopausal Syndrome. J Chin Med 23（2）: 165-181.
Wissing MD. Chemotherapy- and irradiation-induced bone loss in adults with solid tumors. Curr Osteoporos Rep. 2015 Jun;13（3）:140-5. doi: 10.1007/s11914-015-0266-z. PMID: 25712619; PMCID: PMC4417126.
Wu Z （2014） Clinical application of guilu erxian glue. Clin J Chinese Med 6 （17）: 2.
Zhang Y, Mao C, Yan W, Zheng X. Application of cell engineering of herbal Medicine treating bone resorption of osteoclasts. Conf Proc IEEE Eng Med Biol Soc. 2005;2005:4958-61. doi: 10.1109/IEMBS.2005.1615587. PMID: 17281357.
Zhou L, Kuai F, Shi Q, Yang H. Doxorubicin restrains osteogenesis and promotes osteoclastogenesis in vitro. Am J Transl Res. 2020 Sep 15;12（9）:5640-5654. PMID: 33042445; PMCID: PMC7540161.